Patents by Inventor Dorothée Lebert

Dorothée Lebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETECTION AND QUANTIFICATION OF ANTI-DRUG ANTIBODIES AND ANTI-SELF ANTIBODIES
    Publication number: 20250231192
    Abstract: This invention relates to the field of antibody quantification. In particular it relates to the quantification of antibodies in a biological sample; including anti-drug antibodies (ADA), anti-self antibodies (ASA), and mixtures thereof.
    Type: Application
    Filed: February 17, 2023
    Publication date: July 17, 2025
    Applicant: PROMISE PROTEOMICS
    Inventors: Jérôme CHENAU, Dorothée LEBERT
  • Method for quantifying anti-TNF antibodies
    Patent number: 11630111
    Abstract: The present invention relates to a method for quantifying an anti-TNF antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic anti-TNF antibodies a known amount of two or more labeled forms of said anti-TNF antibodies.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: April 18, 2023
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard
  • Method for quantifying therapeutic antibodies
    Patent number: 11543416
    Abstract: The present invention relates to a method for quantifying a therapeutic antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic antibodies to be quantified a known amount of two or more labeled forms of said therapeutic antibodies.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: January 3, 2023
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard
  • Antibody-like peptides for quantifying therapeutic antibodies
    Patent number: 11053303
    Abstract: The present invention relates to a labeled chimeric non-therapeutic antibodylike protein comprising, in a hypervariable region thereof, an enzyme cleavable peptide sequence derived from a hypervariable region of a reference therapeutic antibody.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: July 6, 2021
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard
  • ANTIBODY-LIKE PEPTIDES FOR QUANTIFYING THERAPEUTIC ANTIBODIES
    Publication number: 20190085056
    Abstract: The present invention relates to a labeled chimeric non-therapeutic antibodylike protein comprising, in a hypervariable region thereof, an enzyme cleavable peptide sequence derived from a hypervariable region of a reference therapeutic antibody
    Type: Application
    Filed: September 17, 2018
    Publication date: March 21, 2019
    Applicant: Promise Advanced Proteomics
    Inventors: Dorothée Lebert, Guillaume Picard
  • A Method for Quantifying Therapeutic Antibodies
    Publication number: 20190011455
    Abstract: The present invention relates to a method for quantifying a therapeutic antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic antibodies to be quantified a known amount of two or more labeled forms of said therapeutic antibodies.
    Type: Application
    Filed: November 4, 2016
    Publication date: January 10, 2019
    Applicant: Promise Advanced Proteomics
    Inventors: Dorothée Lebert, Guillaume Picard
  • A Method for Quantifying Anti-TNF Antibodies
    Publication number: 20180321253
    Abstract: The present invention relates to a method for quantifying an anti-TNF antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic anti-TNF antibodies a known amount of two or more labeled forms of said anti-TNF antibodies.
    Type: Application
    Filed: November 4, 2016
    Publication date: November 8, 2018
    Applicant: Promise Advanced Proteomics
    Inventors: Dorothée Lebert, Guillaume Picard